3HB5
Binary and ternary crystal structures of a novel inhibitor of 17 beta-HSD type 1: a lead compound for breast cancer therapy
Functional Information from GO Data
Chain | GOid | namespace | contents |
X | 0003824 | molecular_function | catalytic activity |
X | 0004303 | molecular_function | estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
X | 0005496 | molecular_function | steroid binding |
X | 0005515 | molecular_function | protein binding |
X | 0005737 | cellular_component | cytoplasm |
X | 0005829 | cellular_component | cytosol |
X | 0006629 | biological_process | lipid metabolic process |
X | 0006694 | biological_process | steroid biosynthetic process |
X | 0006703 | biological_process | estrogen biosynthetic process |
X | 0007040 | biological_process | lysosome organization |
X | 0007519 | biological_process | skeletal muscle tissue development |
X | 0008210 | biological_process | estrogen metabolic process |
X | 0010467 | biological_process | gene expression |
X | 0016491 | molecular_function | oxidoreductase activity |
X | 0030283 | molecular_function | testosterone dehydrogenase [NAD(P)+] activity |
X | 0035410 | molecular_function | obsolete dihydrotestosterone 17-beta-dehydrogenase activity |
X | 0036094 | molecular_function | small molecule binding |
X | 0042803 | molecular_function | protein homodimerization activity |
X | 0047035 | molecular_function | testosterone dehydrogenase (NAD+) activity |
X | 0047045 | molecular_function | testosterone 17-beta-dehydrogenase (NADP+) activity |
X | 0050661 | molecular_function | NADP binding |
X | 0060348 | biological_process | bone development |
X | 0060612 | biological_process | adipose tissue development |
X | 0061370 | biological_process | testosterone biosynthetic process |
X | 0070401 | molecular_function | NADP+ binding |
X | 0071248 | biological_process | cellular response to metal ion |
X | 0072582 | molecular_function | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity |
X | 1903924 | molecular_function | estradiol binding |
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 29 |
Details | BINDING SITE FOR RESIDUE NAP X 360 |
Chain | Residue |
X | GLY9 |
X | LEU64 |
X | ASP65 |
X | VAL66 |
X | ARG67 |
X | ASN90 |
X | ALA91 |
X | GLY92 |
X | THR140 |
X | GLY141 |
X | TYR155 |
X | CYS10 |
X | LYS159 |
X | CYS185 |
X | GLY186 |
X | VAL188 |
X | THR190 |
X | PHE192 |
X | HOH344 |
X | HOH370 |
X | HOH404 |
X | HOH419 |
X | SER11 |
X | SER12 |
X | ILE14 |
X | GLY15 |
X | THR35 |
X | LEU36 |
X | ARG37 |
Functional Information from PROSITE/UniProt
site_id | PS00061 |
Number of Residues | 29 |
Details | ADH_SHORT Short-chain dehydrogenases/reductases family signature. SvgglmglpfNdvYCASKFALeGLCeSLA |
Chain | Residue | Details |
X | SER142-ALA170 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 1 |
Details | ACT_SITE: Proton acceptor |
Chain | Residue | Details |
X | TYR155 |
site_id | SWS_FT_FI2 |
Number of Residues | 4 |
Details | BINDING: BINDING => ECO:0000269|PubMed:8805577 |
Chain | Residue | Details |
X | GLY9 | |
X | ASP65 | |
X | SER142 | |
X | LYS159 |
site_id | SWS_FT_FI3 |
Number of Residues | 1 |
Details | MOD_RES: Phosphoserine; by PKA => ECO:0000269|PubMed:8994190 |
Chain | Residue | Details |
X | SER134 |
Catalytic Information from CSA
site_id | CSA1 |
Number of Residues | 2 |
Details | Annotated By Reference To The Literature 1qsg |
Chain | Residue | Details |
X | ASN152 | |
X | LYS159 |
site_id | CSA2 |
Number of Residues | 2 |
Details | Annotated By Reference To The Literature 1qsg |
Chain | Residue | Details |
X | TYR155 | |
X | LYS159 |